Abstract Background Oral lichen planus (OLP) is a chronic inflammatory disease of the oral cavity that affects many patients’ daily living activities. Topical corticosteroids are the first-line drug for treating OLP. The Oral Impact on Daily Performances index (OIDP) is an Oral-Health-Related Quality of Life (OHRQoL) measure developed to assess the ultimate impacts. The aims of this study were to evaluate the clinical, pain and OHRQoL responses after treating OLP patients with topical corticosteroids for 1 month, and secondly to assess the relationships of changes in the clinical sign score, pain score, and OHRQoL. Methods Seventy-two OLP patients were treated by topical corticosteroids based on their dentists’ clinical judgments. Clinical ...
Explore the treatment of oral lichen planus with topical corticosteroids by the healthcare professio...
Thesis (Master's)--University of Washington, 2019Background: Lichen Planus (LP) is a chronic inflamm...
Oral lichen planus (OLP) is a relatively common chronic T cell-mediated disease, which can cause sig...
The aim of this study was to evaluate the sensitivity of two patient-centred outcome measures to the...
Background: Oral lichen planus (OLP) is one of the most prevalent oral mucosal diseases. Aims: The a...
BACKGROUND: Symptomatic oral lichen planus (OLP) has been palliated with a wide spectrum of topical ...
The present study evaluates the performance of patient-centred outcome measures in the oral medicine...
Objectives To examine the factors which affect the improvement or the recurrence of disease after in...
This study aimed to characterize the clinical profile of patients with oral lichen planus (OLP) and ...
Oral lichen planus (OLP) is a common chronic inflammatory disease associated with cell-mediated immu...
AbstractBackground/purposeVarious treatment regimens have been attempted to improve oral lichen plan...
Oral lichen planus (OLP) is a chronic inflammatory disease of the skin and mucous membrane presented...
Background: Total antioxidant capacity (TAC) and malondialdehyde (MDA) levels have not been reported...
OBJECTIVES: The role of dental plaque in gingival lesions caused by oral lichen planus has not bee...
Background and Design: How oral lichen planus (OLP) affects oral health-related quality of life has ...
Explore the treatment of oral lichen planus with topical corticosteroids by the healthcare professio...
Thesis (Master's)--University of Washington, 2019Background: Lichen Planus (LP) is a chronic inflamm...
Oral lichen planus (OLP) is a relatively common chronic T cell-mediated disease, which can cause sig...
The aim of this study was to evaluate the sensitivity of two patient-centred outcome measures to the...
Background: Oral lichen planus (OLP) is one of the most prevalent oral mucosal diseases. Aims: The a...
BACKGROUND: Symptomatic oral lichen planus (OLP) has been palliated with a wide spectrum of topical ...
The present study evaluates the performance of patient-centred outcome measures in the oral medicine...
Objectives To examine the factors which affect the improvement or the recurrence of disease after in...
This study aimed to characterize the clinical profile of patients with oral lichen planus (OLP) and ...
Oral lichen planus (OLP) is a common chronic inflammatory disease associated with cell-mediated immu...
AbstractBackground/purposeVarious treatment regimens have been attempted to improve oral lichen plan...
Oral lichen planus (OLP) is a chronic inflammatory disease of the skin and mucous membrane presented...
Background: Total antioxidant capacity (TAC) and malondialdehyde (MDA) levels have not been reported...
OBJECTIVES: The role of dental plaque in gingival lesions caused by oral lichen planus has not bee...
Background and Design: How oral lichen planus (OLP) affects oral health-related quality of life has ...
Explore the treatment of oral lichen planus with topical corticosteroids by the healthcare professio...
Thesis (Master's)--University of Washington, 2019Background: Lichen Planus (LP) is a chronic inflamm...
Oral lichen planus (OLP) is a relatively common chronic T cell-mediated disease, which can cause sig...